Imprivata, the healthcare IT security company, is going full-force into the patient identification market with its announcement today of its purchase of HT Systems, a provider of vein-scan biometric technology. Executives at Imprivata and HT Systems gave Fortune an exclusive preview of the deal this week, and said they would provide more details at Imprivata’s quarterly earnings call May 4.
Imprivata [fortune-stock symbol= »IMPR »] will pay about $19.1 million in cash plus additional payments for meeting retention and performance standards, which could value the deal at as much as $26 million.
The deal gives the Massachusetts-based Imprivata the technology it needs to develop a patient-facing security segment by expanding the reach of HT Systems’ PatientSecure platform. The biometrics system connects patients to their electronic medical records when they first show up at a hospital or clinic, and then accurately identifies them when they return, helping to prevent expensive insurance fraud and…
Voir l’article original 454 mots de plus